BackBluebird bio Overview

Bluebird bio Total Assets

Bluebird bio's total assets is $300M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$295.96M
↓ 53.13% YoYΔ $-335.53M vs prior year quarter

Peer trimmed avg / median

Loading

Bluebird bio Total Assets History

Loading

Bluebird bio vs. peers: Total Assets Comparison

Loading

Bluebird bio Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bluebird bio (BLUE) FAQ

As of the most recent data (March 2025), BLUE shows a total assets of $300M. That compares with $630M in the prior-year period — down 53.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLUE's total assets is now $300M (was $630M) — a 53.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bluebird bio is outperforming or lagging.

Tracking BLUE's total assets over time shows whether Bluebird bio is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $630M in the prior-year period — down 53.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bluebird bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $300M) with ownership activity and broader fundamentals.

Bluebird bio's total assets is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.